The confidence interval (the line on each bar graph) shows that those who took semaglutide appear to have a statistically significant lower rate of thyroid cancer
Thyroid tumors : There bave been concerns about an increased risk of thyroid tumors, including medullary thyroid carcinoma, in patients using GLP-1 receptor agonists like Ozempic
Preis KA, Seidel G, JR
Purity, sterility, dosing accuracy, and ingredient quality may vary significantly between sources
Quick Stats for Obesity GLP-1 Market Obesity GLP-1 Market Value (2025): USD 8,169 million Obesity GLP-1 Market Forecast Value (2035): USD 65,364 million Obesity GLP-1 Market Forecast CAGR: 23.1% Leading Molecule Class in Obesity GLP-1 Market: Semaglutide (58.0%) Key Growth Regions in Obesity GLP-1 Market: North America, Europe, and East Asia Top Key Players in Obesity GLP-1 Market: Novo Nordisk, Eli Lilly, and emerging manufacturers Between 2025 and 2030, the obesity GLP-1 market is projected to expand from USD 8169.0 million to USD 39,528 million, resulting in a value increase of USD 31359.0 million, which represents 54.8% of the total forecast growth for the decade
People with sleep apnea may also experience daytime fatigue, loud snoring, and restless sleep
S70 - V70" loading="lazy"/>
